Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is alpha1D-adrenoceptor protein detectable in rat tissues?

M Yang1, F Verfürth, R Büscher

  • 1Department of Medicine, University of Essen, Germany.

Naunyn-Schmiedeberg'S Archives of Pharmacology
|April 1, 1997
PubMed
Summary

This study investigated alpha1D-adrenoceptors in rat tissues. Despite mRNA presence, alpha1D-adrenoceptors were not detected at the protein level, suggesting limitations in current detection methods for these adrenoceptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of geriatric patients with benign prostatic hyperplasia].

Der Urologe. Ausg. A·2020
Same author

[Do benign prostatic hyperplasia drugs affect mood or cognition?]

Der Urologe. Ausg. A·2019
Same author

An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational material.

International journal of clinical practice·2014
Same author

The Concise Guide to PHARMACOLOGY 2013/14: overview.

British journal of pharmacology·2014
Same author

Does concomitant diabetes affect treatment responses in overactive bladder patients?

International journal of clinical practice·2013
Same author

Autonomic nervous control of the urinary bladder.

Acta physiologica (Oxford, England)·2012

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Alpha1-adrenoceptors are crucial for various physiological processes.
  • Specific subtypes, including alpha1D-adrenoceptors, play distinct roles.
  • Detecting alpha1D-adrenoceptors at the protein level in native tissues remains challenging.

Purpose of the Study:

  • To investigate the presence of alpha1D-adrenoceptors at the protein level in rat tissues.
  • To correlate protein expression with known alpha1D-adrenoceptor mRNA distribution.
  • To evaluate the utility of various pharmacological tools in detecting alpha1D-adrenoceptors.

Main Methods:

  • Radioligand binding studies using [3H]prazosin.
  • Utilized subtype-selective alpha1-adrenoceptor agonists and antagonists (e.g., BMY 7378, (+)-niguldipine).

Related Experiment Videos

  • Investigated tissues with and without alpha1D-adrenoceptor mRNA, including spleen, cerebral cortex, kidney, and liver, with and without alpha1B-adrenoceptor inactivation.

    • Main Results:

    • Alpha1D-adrenoceptor mRNA was detected in spleen, cerebral cortex, and kidney, but not liver.
    • Radioligand binding studies did not readily detect alpha1D-adrenoceptors at the protein level in these tissues.
    • Agonist and antagonist competition curves in treated tissues did not clearly identify alpha1D-adrenoceptors.

    Conclusions:

    • Alpha1D-adrenoceptors are not easily detectable at the protein level in rat tissues where their mRNA is expressed.
    • The observed biphasic competition curves do not represent alpha1D-adrenoceptors.
    • Current alpha1-adrenoceptor classification may not fully explain experimental findings in native tissues.